The biopsy devices market has benefitted from being suitable for the diagnosis of a variety of cancer indications, and will grow from $506.4m in 2013 to $602.4m in 2019, at a global compound annual growth rate (CAGR) of 2.93%.
Where other companies look to simply sell you a product, we want to form a lasting relationship with our customers. And to us, that "relationship" isn't a buzzword - it means we truly care about you and your unique needs as an oncology treatment prov...
The majority of pre-hospital intubations in the state of Maine are in patients suffering from out-of-hospital cardiac arrest (approximately 83%), and certainly, airway management is essential for these patients.
This white paper identifies current issues with the Health Identifier (HI) service that may impact software vendors, Medical Software Industry Association (MSIA) members and associated software products.
The aim of the white paper is to increase US healthcare innovation and assist Israeli healthcare companies by empowering them to do business in the US market, both independently and through increased partnerships with American companies.
This white paper provides a literature review of incident disclosure research, policy and legal reform documents published since 2008. The last four years have seen an explosion of policy and literature on all aspects of incident disclosure.
This white paper has been developed for outpatient oncology facilities to serve as a model for a basic infection control and prevention plan, containing policies and procedures tailored to meet minimal expectations of patient protections, as describe...
The white paper explains how congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two of the most serious chronic health conditions affecting the rapidly growing population of older Americans.